Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Determine when to stay invested versus selling SP 500 in retirement with a simple framework that prioritizes risk control and income needs.
19,407 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Nike's latest sponsorship moves suggest a gradual return of brand influence and profit potential. This article explor...
Palantir has slipped significantly from its all-time high, prompting questions about a buy-the-dip opportunity. This ...
MercadoLibre's fourth-quarter results showed strong revenue growth, but a notable drop in profitability. This article...
Salesforce surged Thursday as the company announced a major debt offering to back a sizable share repurchase plan. Th...
Insider moves can spark questions about a regional bank's future. This guide explains what a director selling shares ...
Chewy has faced a rough year, with shares falling and growth challenges ahead. Yet, a closer look under the hood show...
When doximity stock plunged today, the market focused on earnings quality and future profitability. This article brea...
When a major holding shows a sharp fall after earnings, investors scramble for answers. This guide breaks down the re...
As earnings season arrives, sprinklr (cxm) 2026 earnings take center stage for investors watching the CXM software sp...
NVIDIA shares pulled back amid an AI sector-wide retreat, but a growing data-center footprint and a record order book...
Viasat stock went moon as part of a broader space-sector rally. This article dives into the drivers, what it means fo...